000953 河化股份
已收盘 04-30 15:00:00
资讯
新帖
简况
河化股份:2023年,公司研发项目主要集中在医药中间体、药用辅料、日用精细化学品、原料药的开发
证券之星 · 04-28
河化股份:2023年,公司研发项目主要集中在医药中间体、药用辅料、日用精细化学品、原料药的开发
图解河化股份一季报:第一季度单季净利润同比增26.10%
证券之星 · 04-26
图解河化股份一季报:第一季度单季净利润同比增26.10%
图解河化股份年报:第四季度单季净利润同比增91.97%
证券之星 · 04-26
图解河化股份年报:第四季度单季净利润同比增91.97%
河化股份(000953.SZ)发布一季度业绩 净亏损116万元
智通财经 · 04-26
河化股份(000953.SZ)发布一季度业绩 净亏损116万元
河化股份下跌5.2%,报4.19元/股
金融界网站 · 01-31
河化股份下跌5.2%,报4.19元/股
河化股份(000953.SZ)拟以9450万元转让公司尿素产能指标
智通财经网 · 2023-12-10
河化股份(000953.SZ)拟以9450万元转让公司尿素产能指标
暂无数据
公司概况
公司名称:
广西河池化工股份有限公司
所属行业:
医药制造业
上市日期:
1999-12-02
主营业务:
广西河池化工股份有限公司的主营业务是医药中间体的研发、生产与销售业务以及尿素委托加工销售业务。公司主要产品是抗疟疾类、孕激素类、营养剂类药物中间体、尿素。公司是广西重点化肥骨干企业和河池市目前唯一一家上市公司,中国500家最大化学工业企业之一(排名第123位)。
发行价格:
4.15
{"stockData":{"symbol":"000953","market":"SZ","secType":"STK","nameCN":"河化股份","latestPrice":3.28,"timestamp":1714460619000,"preClose":3.33,"halted":0,"volume":13125600,"delay":0,"floatShares":366000000,"shares":366000000,"eps":-0.0305,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.05,"latestTime":"04-30 15:00:00","open":3.33,"high":3.36,"low":3.18,"amount":42948000,"amplitude":0.0541,"askPrice":3.29,"askSize":330,"bidPrice":3.28,"bidSize":78,"shortable":0,"etf":0,"ttmEps":-0.0305,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":3.33,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":3.66,"lowLimit":3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":366122195,"pbRate":18.51,"roa":"--","roe":"--","epsLYR":-0.03,"committee":-0.657168,"marketValue":1201000000,"floatMarketCap":1201000000,"peRate":-107.540982,"changeRate":-0.015,"turnoverRate":0.0359,"status":1},"requestUrl":"/m/hq/s/000953/tweets","defaultTab":"tweets","newsList":[{"id":"2430650880","title":"河化股份:2023年,公司研发项目主要集中在医药中间体、药用辅料、日用精细化学品、原料药的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2430650880","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430650880?lang=zh_cn&edition=full","pubTime":"2024-04-28 23:00","pubTimestamp":1714316434,"startTime":"0","endTime":"0","summary":"南松2023年收入大幅增长情况下出现亏损,主要原因:1、2023年南松实施的技改项目投入试运行,试运行期间设备磨合、工艺调整,以及新研制的产品下游客户认证时间长,市场推广不理想、订单不足等原因,生产装置未能正常运营,导致生产成本较高,停工损失增加较多。2023年,公司研发项目主要集中在医药中间体、药用辅料、日用精细化学品、原料药的开发。项目来源有自主研发、委托开发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800009812.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430230047","title":"图解河化股份一季报:第一季度单季净利润同比增26.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430230047","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430230047?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:21","pubTimestamp":1714069281,"startTime":"0","endTime":"0","summary":"证券之星消息,河化股份2024年一季报显示,公司主营收入6191.78万元,同比上升7.11%;归母净利润-116.0万元,同比上升26.1%;扣非净利润-121.56万元,同比上升11.77%;负债率70.91%,财务费用80.02万元,毛利率12.09%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600003262.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430234483","title":"图解河化股份年报:第四季度单季净利润同比增91.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430234483","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430234483?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:58","pubTimestamp":1714064305,"startTime":"0","endTime":"0","summary":"证券之星消息,河化股份2023年年报显示,公司主营收入1.87亿元,同比上升16.74%;归母净利润-1155.92万元,同比上升88.49%;扣非净利润-1202.69万元,同比上升88.65%;其中2023年第四季度,公司单季度主营收入3618.11万元,同比上升25.96%;单季度归母净利润-773.23万元,同比上升91.97%;单季度扣非净利润-870.52万元,同比上升91.01%;负债率70.52%,财务费用276.58万元,毛利率12.04%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600000874.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430231861","title":"河化股份(000953.SZ)发布一季度业绩 净亏损116万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430231861","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430231861?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:40","pubTimestamp":1714063233,"startTime":"0","endTime":"0","summary":"智通财经APP讯,河化股份(000953.SZ)披露2024年第一季度报告,该公司报告期实现营业收入6191.78万元,同比增长7.11%。归属于上市公司股东的净亏损116.00万元,同比收窄26.10%。归属于上市公司股东的扣除非经常性损益的净亏损121.56万元,同比收窄11.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111097.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2407321929","title":"河化股份下跌5.2%,报4.19元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2407321929","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2407321929?lang=zh_cn&edition=full","pubTime":"2024-01-31 10:40","pubTimestamp":1706668800,"startTime":"0","endTime":"0","summary":"转自:金融界本文源自:金融界1月31日,河化股份盘中下跌5.2%,截至10:28,报4.19元/股,成交1611.62万元,换手率1.01%,总市值15.34亿元。2019年,公司通过发行股份购买资产并募集配套资金1.2亿收购南松医药93.41%股权。截至9月30日,河化股份股东户数2.28万,人均流通股1.6万股。2023年1月-9月,河化股份实现营业收入1.51亿元,同比增长14.73%;归属净利润-382.69万元,同比增长6.59%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-01-31/doc-inafkseh1817416.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-01-31/doc-inafkseh1817416.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2390822123","title":"河化股份(000953.SZ)拟以9450万元转让公司尿素产能指标","url":"https://stock-news.laohu8.com/highlight/detail?id=2390822123","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2390822123?lang=zh_cn&edition=full","pubTime":"2023-12-10 17:01","pubTimestamp":1702198860,"startTime":"0","endTime":"0","summary":"河化股份发布公告,2019年末2020年初实施了重大资产重组,重组完成后,公司主业由化肥产品的生产与销售变更为医药中间体的研发、生产、销售及技术推广以及尿素委托加工销售业务。经双方友好协商,拟以人民币9450万元进行转让。因此,公司亟需在相应窗口期内尽快推进尿素产能指标转让的事宜。预计本次转让35万吨尿素产能指标扣除各项税费后可获得约8800万元的转让收益,占最近一期经审计归母净利润50%以上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-10/doc-imzxpkxu8488570.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-10/doc-imzxpkxu8488570.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-12-02","address":"广西壮族自治区河池市金城江区六甲镇","stockEarnings":[{"period":"1week","weight":0.1156},{"period":"1month","weight":-0.1568},{"period":"3month","weight":-0.2077},{"period":"6month","weight":-0.4276},{"period":"1year","weight":-0.4174},{"period":"ytd","weight":-0.4004}],"companyName":"广西河池化工股份有限公司","boardCode":"AI0027","perCapita":"15997股","boardName":"医药制造业","registeredCapital":"36612万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 广西河池化工股份有限公司的主营业务是医药中间体的研发、生产与销售业务以及尿素委托加工销售业务。公司主要产品是抗疟疾类、孕激素类、营养剂类药物中间体、尿素。公司是广西重点化肥骨干企业和河池市目前唯一一家上市公司,中国500家最大化学工业企业之一(排名第123位)。","serverTime":1714688431174,"listedPrice":4.15,"stockholders":"22886人(较上一季度增加6.36%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"河化股份(000953)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供河化股份(000953)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"河化股份,000953,河化股份股票,河化股份股票老虎,河化股份股票老虎国际,河化股份行情,河化股份股票行情,河化股份股价,河化股份股市,河化股份股票价格,河化股份股票交易,河化股份股票购买,河化股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"河化股份(000953)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供河化股份(000953)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}